KIT and lymphoid leukemia: In keeping with a role for IRX3 in promoting the development of lymphoid leukemias, we found that irradiated congenic mice transplanted with IRX3-expressing KIT+ BM HSPCs developed lymphoid leukemias with incomplete penetrance.